Napravi najbolje investicije svog života.

Od 2 evra osigurajте
Analiza akcija
Profil
Health Sciences - Akcija

Health Sciences Akcija

IWKS
US0010582056

Cena

0,50 USD
Danas +/-
+0 USD
Danas %
+0 %
P

Health Sciences Akcija Promet, EBIT, Dobit

  • 3 godine

  • 5 godina

  • 10 godina

  • Maks

Promet
EBIT
Profit
Detalji

Promet, Profit & EBIT

Razumevanje prometa, EBIT-a i prihoda

Dobijte uvid u Health Sciences, sveobuhvatan pregled finansijskih performansi može se dobiti analizom dijagrama prometa, EBIT-a i prihoda. Promet predstavlja ukupni prihod koji Health Sciences ostvaruje iz svojih glavnih poslova i pokazuje sposobnost kompanije da privlači i zadržava klijente. EBIT (Earnings Before Interest and Taxes) pruža informacije o operativnoj profitabilnosti kompanije, oslobođen od poreskih i kamatnih troškova. Deo prihoda odražava neto profit Health Sciences, krajnju meru njegovog finansijskog zdravlja i profitabilnosti.

Godišnja analiza i poređenja

Pogledajte godišnje stubove kako biste razumeli godišnje performanse i rast Health Sciences. Uporedite promet, EBIT i prihod kako biste procenili efikasnost i profitabilnost kompanije. Veći EBIT u poređenju s prošlom godinom ukazuje na unapređenje operativne efikasnosti. Slično tome, povećanje prihoda ukazuje na povećanu ukupnu profitabilnost. Analiza poređenja iz godine u godinu pomaže investitorima da razumeju rast i operativnu efikasnost kompanije.

Koristite očekivanja za investiranje

Predviđene vrednosti za naredne godine pružaju investitorima uvid u očekivane finansijske performanse Health Sciences. Analiza ovih prognoza zajedno s istorijskim podacima pomaže da se donesu informisane investicione odluke. Investitori mogu proceniti potencijalne rizike i prinose i uskladiti svoje investicione strategije kako bi optimizovali profitabilnost i smanjili rizike.

Uvid u investicije

Upoređivanje prometa i EBIT-a pomaže u proceni operativne efikasnosti Health Sciences, dok upoređivanje prometa i prihoda otkriva neto profitabilnost nakon uzimanja u obzir svih troškova. Investitori mogu steći dragocene uvide analizirajući ove finansijske parametre pažljivo i tako postaviti temelj za strateške investicione odluke kako bi iskoristili potencijal za rast Health Sciences.

Health Sciences Prihod, dobit i EBIT istorija

DatumHealth Sciences PrometHealth Sciences EBITHealth Sciences Profit
200834,28 mil. USD-4,41 mil. USD-11,05 mil. USD
200728,72 mil. USD-933.000,00 USD-4,67 mil. USD
200625,00 mil. USD1,04 mil. USD1,00 mil. USD
200523,14 mil. USD1,35 mil. USD1,90 mil. USD
200419,83 mil. USD1,45 mil. USD1,35 mil. USD
200318,04 mil. USD0 USD-1,52 mil. USD
200220,09 mil. USD390.000,00 USD90.000,00 USD
200124,05 mil. USD-380.000,00 USD-1,74 mil. USD
200025,37 mil. USD-430.000,00 USD-810.000,00 USD
199929,37 mil. USD-930.000,00 USD-2,21 mil. USD
199833,77 mil. USD520.000,00 USD-3,33 mil. USD
199737,05 mil. USD2,13 mil. USD1,55 mil. USD
199636,53 mil. USD1,54 mil. USD700.000,00 USD
199526,59 mil. USD1,52 mil. USD920.000,00 USD
199430,51 mil. USD180.000,00 USD-4,18 mil. USD
199338,26 mil. USD1,57 mil. USD-1,26 mil. USD
199238,26 mil. USD970.000,00 USD-530.000,00 USD
199138,03 mil. USD10.000,00 USD-1,19 mil. USD
199048,29 mil. USD2,75 mil. USD420.000,00 USD
198945,45 mil. USD2,31 mil. USD-190.000,00 USD

Health Sciences Akcija Kennzahlen

  • Jednostavno

  • Prošireno

  • GuV

  • Bilans

  • Keš flou

 
PRIHOD (mil. USD)RAST PRIHODA (%)BRUTO MARGINA (%)BRUTO PRIHOD (mil. USD)EBIT (mil. USD)EBIT-MARGA (%)NETO DOBITAK (hilj. USD)Rast dobiti (%)BROJ AKCIJA (hilj.)DOKUMENTA
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008
10,0014,0017,0016,0019,0043,0045,0048,0038,0038,0038,0030,0026,0036,0037,0033,0029,0025,0024,0020,0018,0019,0023,0024,0028,0034,00
-40,0021,43-5,8818,75126,324,656,67-20,83---21,05-13,3338,462,78-10,81-12,12-13,79-4,00-16,67-10,005,5621,054,3516,6721,43
40,0042,8629,4131,2531,5832,5631,1131,2526,3228,9528,9530,0034,6233,3332,4330,3027,5928,0029,1730,0033,3336,8434,7837,5035,7141,18
4,006,005,005,006,0014,0014,0015,0010,0011,0011,009,009,0012,0012,0010,008,007,007,006,006,007,008,009,0010,0014,00
1,002,0001,001,003,002,002,00001,0001,001,002,000000001,001,001,000-4,00
10,0014,29-6,255,266,984,444,17--2,63-3,852,785,41------5,264,354,17--11,76
00000000-1.000,000-1.000,00-4.000,00001.000,00-3.000,00-2.000,000-1.000,000-1.000,001.000,001.000,001.000,00-4.000,00-11.000,00
-----------300,00----400,00-33,33-----200,00---500,00175,00
10,0010,0010,0010,0010,0010,0010,0010,0010,0010,0010,0010,0010,0020,0010,0020,0020,0020,0020,0020,0018,5419,2619,7721,0327,2735,86
- - - - - - - - - - - - - - - - - - - - - - - - - -
Detalji

GuV

Prihod i rast

Prihod Health Sciences i rast prihoda su ključni za razumevanje finansijskog zdravlja i operativne efikasnosti kompanije. Konstantan rast prihoda ukazuje na sposobnost kompanije da efektivno tržišno plasira i prodaje svoje proizvode ili usluge, dok procentualni rast prihoda pokazuje brzinu rasta kompanije tokom godina.

Bruto marža

Bruto marža je ključni faktor koji pokazuje procenat prihoda iznad proizvodnih troškova. Viša bruto marža ukazuje na efikasnost kompanije u kontroli proizvodnih troškova i obećava potencijalnu profitabilnost I finansijsku stabilnost.

EBIT i EBIT marža

EBIT (Earnings Before Interest and Taxes) i EBIT marža pružaju duboke uvide u profitabilnost kompanije, bez uticaja kamata i poreza. Investitori često procenjuju ove metrike kako bi ocenili operativnu efikasnost i inherentnu profitabilnost kompanije nezavisno od njene finansijske strukture i poreskog okruženja.

Prihod i rast

Neto prihod i njegov kasniji rast su neophodni investitorima koji žele da razumeju profitabilnost kompanije. Konstantan rast prihoda naglašava sposobnost kompanije da povećava svoju profitabilnost tokom vremena i odražava operativnu efikasnost, stratešku konkurentnost i finansijsko zdravlje.

Izdate akcije

Izdate akcije se odnose na ukupan broj akcija koje je kompanija izdala. Ovo je ključno za izračunavanje bitnih pokazatelja kao što je zarada po akciji (EPS), koji je za investitore od kritične važnosti da procene profitabilnost kompanije po osnovu po akciji i pruža detaljniji pregled finansijskog zdravlja i vrednovanja.

Interpretacija godišnje usporedbe

Usporedba godišnjih podataka omogućuje investitorima da identifikuju trendove, procene rast kompanije i predviđaju potencijalne buduće performanse. Analiza kako se pokazatelji kao što su prihod, dohodak i marže menjaju iz godine u godinu može pružiti dragocene uvide u operativnu efikasnost, konkurentnost i finansijsko zdravlje kompanije.

Očekivanja i prognoze

Investitori često upoređuju trenutne i prošle finansijske podatke sa tržišnim očekivanjima. Ovaj uporedni pregled pomaže u ocenjivanju da li kompanija Health Sciences postiže rezultate u skladu sa očekivanjima, ispod ili iznad proseka i pruža ključne podatke za odluke o investiranju.

 
AKTIVAREZERVNI NOVČANI FOND (mil. USD)POTRAŽIVANJA (mil. USD)S. POTRAŽIVANJA (mil. USD)ZAALIHE (mil. USD)О. ТЕКУЋА ИМОВИНА (mil. USD)ОБРТНА СРЕДСТВА (mil. USD)MATERIJALNA IMOVINA (mil. USD)DUGOR. INVEST. (mil. USD)LANGF. FORDER. (mil. USD)IMAT. IMOVINSKI RAČ. (mil. USD)GOODWILL (mil. USD)S. ULAGANJA. (mil. USD)OSNOVNA SREDSTVA (mil. USD)UKUPNA IMOVINA (mil. USD)PASIVAOBIČNE AKCIJE (mil. USD)KAPITALNE REZERVE (mil. USD)REZERVISANI DOBITAK (mil. USD)S. SOPSTVENI KAP. (mil. USD)N. REAL. KURSG./-V. (mil. USD)KAPITAL VLASTI (mil. USD)OBAVEZE (mil. USD)REZERVACIJA (mil. USD)Kratkoročne obaveze (mil. USD)KRATKOROČNI DUGOVI (mil. USD)LANGF. DUŽNIČKI KAPITAL (mil. USD)KRATK. POTR. (mil. USD)LANGF. VEZA (mil. USD)LATENTNI POREZI (mil. USD)S. VEZA. (mil. USD)LANGF. VEZA (mil. USD)OBVEZE (mil. USD)UKUPNI KAPITAL (mil. USD)
Detalji

Bilans

Razumevanje bilansa

Bilans kompanije Health Sciences pruža detaljan finansijski pregled i prikazuje sredstva, obaveze i kapital u određenom trenutku. Analiza ovih komponenti je ključna za investitore koji žele da razumeju finansijsko zdravlje i stabilnost kompanije Health Sciences.

Sredstva

Sredstva kompanije Health Sciences predstavljaju sve što kompanija poseduje ili kontroliše i što ima novčanu vrednost. Ova se podeljena na obrtna i dugotrajna sredstva i pružaju uvid u likvidnost i dugoročne investicije kompanije.

Obaveze

Obaveze su dugovi koje će kompanija Health Sciences morati da izmiri u budućnosti. Analiza odnosa obaveza prema sredstvima daje informacije o finansijskoj poluzi i riziku kojem je kompanija izložena.

Kapital

Kapital se odnosi na preostali interes u sredstvima kompanije Health Sciences nakon odbijanja obaveza. Predstavlja potraživanje vlasnika na sredstva i prihode kompanije.

Analiza iz godine u godinu

Upoređivanje podataka iz bilansa iz godine u godinu omogućava investitorima da prepoznaju trendove, uzorke rasta i potencijalne finansijske rizike te da donose informisane odluke o investiranju.

Interpretacija podataka

Detaljna analiza sredstava, obaveza i kapitala može investitorima pružiti sveobuhvatan uvid u finansijsko stanje kompanije Health Sciences i pomoći im u proceni investicija i oceni rizika.

 
NETO DOBIT (hilj. USD)AMORTIZACIJA (hilj. USD)ODLOŽENI POREZI (hilj. USD)PROMENE OBRATNOG KAPITALA (mil. USD)STAVKE BEZ GOTOVINE (mil. USD)PLAĆENE KAMATE (mil. USD)PLAĆENI POREZI (hilj. USD)NETO-CASHFLOW IZ POSLOVNE AKTIVNOSTI (mil. USD)KAPITALNE INVESTICIJE (mil. USD)CASHFLOW IZ INVESTICIONE AKTIVNOSTI (hilj. USD)CASHFLOW OD DRUGIH INVESTICIONIH AKTIVNOSTI (hilj. USD)PRIHODI I RASHODI OD KAMATA (mil. USD)NETO PROMENA DUGA (mil. USD)NETO PROMENA KAPITALA (mil. USD)CASHFLOW FINANSIJSKE AKTIVNOSTI (mil. USD)CASHFLOW OD OSTALIH FINANSIJSKIH AKTIVNOSTI (USD)UKUPNO ISPLAĆENI DIVIDENDI (mil. USD)NETO PROMENA U CASH FLOW-u (mil. USD)SLOBODAN CASH FLOW (mil. USD)KOMPENZACIJA ZASNOVANA NA AKCIJAMA (mil. USD)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008
00000-1.000,000-1.000,00-4.000,00001.000,00-3.000,00-2.000,000-1.000,000-1.000,001.000,001.000,001.000,00-4.000,00-11.000,00
01.000,001.000,001.000,001.000,001.000,001.000,000000000000000001.000,00
00000000000000000000001.000,00
001,00001,003,0002,001,00-3,002,00-1,0001,001,000000000
00000002,002,000003,001,000001,000003,005,00
001,002,002,001,001,001,001,0000000000000001,00
0000000000000000000001.000,000
1,002,003,001,0001,003,001,001,002,00-1,005,00001,001,001,00001,000-1,00-2,00
00000000000000000000000
-2.000,000-13.000,000000001.000,00-3.000,00-2.000,00-1.000,0000000000-17.000,000
-2.000,000-13.000,000000001.000,00-3.000,00-1.000,00000000000-17.000,000
00000000000000000000000
2,0008,0000-1,00-3,00-1,00-1,00-4,005,00-4,0000-1,00-1,00-1,000-1,00007,001,00
00000000002,000000000005,008,000
2,0008,0000-1,00-3,00-1,00-1,00-4,007,00-4,0000-1,00-1,00-1,000-1,0004,0014,001,00
-----------------------
00000000000000000000000
01,00-2,0000000002,00-1,00-1,0000000004,00-4,000
0,672,312,770,610,281,113,550,961,492,78-1,415,25-1,140,151,420,821,120,240,770,950,73-1,80-2,50
00000000000000000000000

Health Sciences Акција Маргине

Health Sciences анализа маржи приказује бруто маржу, ЕБИТ маржу, као и маржу добити компаније Health Sciences. ЕБИТ маржа (ЕБИТ/продаја) указује колики проценат од продате робе остаје као оперативни добитак. Маржа добити показује колики проценат продате робе компаније Health Sciences остаје.
  • 3 godine

  • 5 godina

  • 10 godina

  • Maks

Bruto marža
EBIT marža
Profitna marža
Detalji

Margine

Razumevanje bruto marže

Bruto marža, izražena u procentima, pokazuje bruto dobit od prodaje Health Sciences. Viši procenat bruto marže znači da Health Sciences zadržava više prihoda nakon što su uzeti u obzir troškovi prodatih roba. Investitori koriste ovaj pokazatelj da ocene finansijsko zdravlje i operativnu efikasnost, i da je uporede sa konkurentima i prosečnim vrednostima u industriji.

Analiza marže EBIT

Marža EBIT predstavlja profit Health Sciences pre kamata i poreza. Analiza marže EBIT kroz različite godine pruža uvide u operativnu profitabilnost i efikasnost, bez efekata finansijskog leveraginga i poreske strukture. Rastuća marža EBIT tokom godina signalizira poboljšanu operativnu izvedbu.

Uvidi u maržu obrta

Marža obrta pokazuje ukupan promet koji Health Sciences ostvari. Upoređivanjem marže obrta iz godine u godinu, investitori mogu da procene rast i širenje tržišta Health Sciences. Važno je uporediti maržu obrta sa bruto i EBIT maržom, kako bi se bolje razumele strukture troškova i profita.

Tumačenje očekivanja

Očekivane vrednosti za bruto, EBIT i maržu obrta daju budući finansijski izgled Health Sciences. Investitori bi trebali da uporede ova očekivanja sa istorijskim podacima kako bi razumeli potencijalni rast i faktore rizika. Presudno je uzeti u obzir pretpostavke i metode koje su korišćene za prognozu ovih očekivanih vrednosti kako bi se donosile informisane investicione odluke.

Analiza poređenja

Poređenje bruto, EBIT i marži obrta, godišnje i kroz više godina, omogućuje investitorima da izvrše sveobuhvatnu analizu finansijskog zdravlja i perspektive rasta Health Sciences. Procena trendova i obrazaca u tim maržama pomaže u identifikovanju snaga, slabosti i potencijalnih investicionih prilika.

Health Sciences Istorija margine

Health Sciences Bruto maržaHealth Sciences Profitna maržaHealth Sciences EBIT maržaHealth Sciences Profitna marža
200842,28 %-12,86 %-32,23 %
200737,80 %-3,25 %-16,27 %
200637,31 %4,14 %4,02 %
200538,67 %5,85 %8,21 %
200438,60 %7,33 %6,79 %
200334,24 %0 %-8,40 %
200233,90 %1,94 %0,45 %
200131,56 %-1,58 %-7,23 %
200030,59 %-1,69 %-3,19 %
199930,34 %-3,17 %-7,52 %
199831,21 %1,54 %-9,86 %
199732,66 %5,75 %4,18 %
199633,12 %4,22 %1,92 %
199534,45 %5,72 %3,46 %
199430,97 %0,59 %-13,70 %
199331,05 %4,10 %-3,29 %
199228,93 %2,54 %-1,39 %
199126,30 %0,03 %-3,13 %
199031,81 %5,69 %0,87 %
198932,67 %5,08 %-0,42 %

Health Sciences акција промет, EBIT, добит по акцији

Health Sciences-промет по акцији отуда показује колико промета Health Sciences у једном периоду припада свакој акцији. EBIT по акцији показује колико оперативног профита припада свакој акцији. Добит по акцији указује колико профита припада свакој акцији.
  • 3 godine

  • 5 godina

  • 10 godina

  • Maks

Prihod po akciji
EBIT po akciji
Dobit po akciji
Detalji

Promet, EBIT i Zarada po deonici

Promet po deonici

Promet po deonici predstavlja ukupan promet koji Health Sciences ostvaruje, podeljen brojem izdatih deonica. To je ključna metrika, jer odražava sposobnost kompanije da generiše promet i pokazuje potencijal za rast i širenje. Godišnja poređenja prometa po deonici omogućuju investitorima da analiziraju postojanost prihoda kompanije i predviđaju buduće trendove.

EBIT po deonici

EBIT po deonici označava dobit Health Sciences pre kamata i poreza, i pruža uvid u operativnu profitabilnost, ne uzimajući u obzir efekte kapitalne strukture i poreske stope. Može se uporediti s prometom po deonici kako bi se ocenila efikasnost pretvaranja prodaje u profit. Konstantan porast EBIT-a po deonici tokom godina naglašava operativnu efikasnost i profitabilnost.

Prihod po deonici

Prihod po deonici ili Zarada po deonici (EPS) pokazuje deo dobiti Health Sciences koji se dodeljuje svakoj deonici osnovnog kapitala. To je ključno za ocenu profitabilnosti i finansijskog zdravlja. Poređenjem s prometom i EBIT-om po deonici, investitori mogu videti koliko efikasno kompanija pretvara promet i operativni profit u neto prihod.

Očekivane vrednosti

Očekivane vrednosti su prognoze za promet, EBIT i prihod po deonici za naredne godine. Ove prognoze, koje se baziraju na istorijskim podacima i tržišnim analizama, pomažu investitorima da strategizuju svoje investicije, ocene buduće poslovanje Health Sciences i procene buduće cene deonica. Međutim, ključno je uzeti u obzir tržišne volatilnosti i neizvesnosti koje mogu uticati na ove prognoze.

Health Sciences Promet, dobit i EBIT po akciji - istorija

DatumHealth Sciences Prihod po akcijiHealth Sciences EBIT po akcijiHealth Sciences Dobit po akciji
2008955,94 USD-122,89 USD-308,11 USD
20071.053,17 USD-34,21 USD-171,32 USD
20061.188,68 USD49,26 USD47,74 USD
20051.170,21 USD68,49 USD96,11 USD
20041.029,75 USD75,49 USD69,89 USD
2003973,25 USD0 USD-81,72 USD
20021.004,50 USD19,50 USD4,50 USD
20011.202,50 USD-19,00 USD-87,00 USD
20001.268,50 USD-21,50 USD-40,50 USD
19991.468,50 USD-46,50 USD-110,50 USD
19981.688,50 USD26,00 USD-166,50 USD
19973.705,00 USD213,00 USD155,00 USD
19961.826,50 USD77,00 USD35,00 USD
19952.659,00 USD152,00 USD92,00 USD
19943.051,00 USD18,00 USD-418,00 USD
19933.826,00 USD157,00 USD-126,00 USD
19923.826,00 USD97,00 USD-53,00 USD
19913.803,00 USD1,00 USD-119,00 USD
19904.829,00 USD275,00 USD42,00 USD
19894.545,00 USD231,00 USD-19,00 USD

Health Sciences Akcija i analiza akcija

The Health Sciences Corp is a company that has been active in the biotechnology industry since 1997. It was founded with the goal of developing practical and innovative solutions for medical problems. The company is based in Toronto, Canada, and operates worldwide. The business model of the Health Sciences Corp includes several divisions, all focused on the field of biotechnology. The main divisions are the development of diagnostic tests, drug development, and the production of medical devices. In the field of diagnostic tests, the Health Sciences Corp offers various products that are intended to contribute to faster and more accurate disease diagnosis. An example of this is the reliable blood glucose test, which is particularly used in the diagnosis of diabetes and other metabolic diseases. The company also offers tests for the detection of infectious diseases such as HIV or hepatitis. In the area of drug development, the Health Sciences Corp focuses on developing innovative solutions for particularly difficult-to-treat diseases. These include cancer, autoimmune, and neurodegenerative diseases. Both completely new active substances and novel combinations of existing therapies are developed for this purpose. In addition to drug development, the company also works on the production of medical products. This includes implants as well as devices for monitoring vital parameters. An example of this is the wireless sensor for monitoring heart rhythm disorders, which is applied to the patient's skin and transfers data to the doctor's mobile phone. Over the years, the Health Sciences Corp has received numerous awards and prizes for technological innovations as well as medical research. The company makes a particularly significant contribution to cancer research. It works closely with renowned research institutions and universities, thus constantly contributing to new findings. The knowledge gained in the process also flows into the development of new therapies. In 2016, the Health Sciences Corp founded a subsidiary called MaRS Innovation, which aims to commercialize technology from Canadian universities. The goal is to transform new technologies that have been researched in universities into commercial products and services. The vision of the Health Sciences Corp is to contribute to sustainably improving healthcare for people worldwide through innovative therapies and medications. In addition, the company places great importance on adhering to ethical and moral standards and behaving respectfully towards the environment and society. Overall, the company has an excellent reputation in the biotechnology industry and is considered a pioneer in the development of practical and innovative solutions for medical problems. Health Sciences je jedna od najpopularnijih kompanija na Eulerpool.com.

Health Sciences Ocena na osnovu istorijskog KGV, EBIT i KUV

Health Sciences Broj akcija

  • 3 godine

  • 5 godina

  • 10 godina

  • Maks

Broj akcija
Detalji

Promet, EBIT i Zarada po deonici

Promet po deonici

Promet po deonici predstavlja ukupan promet koji Health Sciences ostvaruje, podeljen brojem izdatih deonica. To je ključna metrika, jer odražava sposobnost kompanije da generiše promet i pokazuje potencijal za rast i širenje. Godišnja poređenja prometa po deonici omogućuju investitorima da analiziraju postojanost prihoda kompanije i predviđaju buduće trendove.

EBIT po deonici

EBIT po deonici označava dobit Health Sciences pre kamata i poreza, i pruža uvid u operativnu profitabilnost, ne uzimajući u obzir efekte kapitalne strukture i poreske stope. Može se uporediti s prometom po deonici kako bi se ocenila efikasnost pretvaranja prodaje u profit. Konstantan porast EBIT-a po deonici tokom godina naglašava operativnu efikasnost i profitabilnost.

Prihod po deonici

Prihod po deonici ili Zarada po deonici (EPS) pokazuje deo dobiti Health Sciences koji se dodeljuje svakoj deonici osnovnog kapitala. To je ključno za ocenu profitabilnosti i finansijskog zdravlja. Poređenjem s prometom i EBIT-om po deonici, investitori mogu videti koliko efikasno kompanija pretvara promet i operativni profit u neto prihod.

Očekivane vrednosti

Očekivane vrednosti su prognoze za promet, EBIT i prihod po deonici za naredne godine. Ove prognoze, koje se baziraju na istorijskim podacima i tržišnim analizama, pomažu investitorima da strategizuju svoje investicije, ocene buduće poslovanje Health Sciences i procene buduće cene deonica. Međutim, ključno je uzeti u obzir tržišne volatilnosti i neizvesnosti koje mogu uticati na ove prognoze.

Trenutno, nažalost, nema dostupnih ciljanih cena i prognoza za Health Sciences.

Česta pitanja o Health Sciences akciji

What values and corporate philosophy does Health Sciences represent?

Health Sciences Corp is committed to upholding certain values and embracing a specific corporate philosophy. The company focuses on promoting excellence, innovation, and ethical business practices. With a strong dedication to providing high-quality healthcare solutions, Health Sciences Corp puts patients at the center of its operations. The company also prioritizes collaboration and teamwork among its employees, ensuring a unified approach for delivering effective medical services. By constantly seeking advancements in medical technology and research, Health Sciences Corp aims to make meaningful contributions to the healthcare industry and improve patient outcomes.

In which countries and regions is Health Sciences primarily present?

Health Sciences Corp primarily operates in the United States, with its headquarters located in California. It has a strong presence across various regions within the country, including New York, Texas, Florida, and Illinois. The company's focus on providing innovative healthcare solutions has enabled it to establish a significant market presence in the US healthcare industry. Health Sciences Corp continues to expand its reach and influence within the American market, enhancing its position as a leading provider of healthcare services and solutions.

What significant milestones has the company Health Sciences achieved?

Health Sciences Corp has achieved several significant milestones. The company has made remarkable progress in the field of medical research and development. With its cutting-edge technologies, Health Sciences Corp has successfully launched innovative products that have revolutionized healthcare practices. Additionally, the company has successfully obtained regulatory approvals for its flagship drugs and expanded its market presence nationally and internationally. Health Sciences Corp has also established strategic collaborations with renowned organizations, enhancing its research capabilities and furthering advancements in healthcare. These achievements have positioned Health Sciences Corp as a market leader and a trusted name in the industry.

What is the history and background of the company Health Sciences?

Health Sciences Corp is a renowned company in the healthcare industry. Founded several decades ago, it has a rich history of providing cutting-edge medical solutions and improving patient care. Specializing in various medical disciplines, Health Sciences Corp has emerged as a global leader in healthcare innovation. Throughout its history, the company has demonstrated a strong commitment to research and development, fostering collaborations with prominent medical institutions. With a diverse portfolio of products and services, Health Sciences Corp continues to revolutionize the healthcare landscape and contribute significantly to the well-being of individuals worldwide.

Who are the main competitors of Health Sciences in the market?

The main competitors of Health Sciences Corp in the market include notable companies like Johnson & Johnson, Pfizer, Novartis, and Merck & Co. These competitors operate in the pharmaceutical and healthcare industry, offering similar products and services. Health Sciences Corp faces competitive challenges in terms of research and development, market share, and innovation from these industry rivals. By continually striving to provide cutting-edge healthcare solutions, Health Sciences Corp aims to maintain a strong competitive position in the market.

In which industries is Health Sciences primarily active?

Health Sciences Corp is primarily active in the healthcare and pharmaceutical industries. Its focus lies in conducting advanced research, development, and commercialization of innovative solutions that address critical medical needs. By leveraging cutting-edge technologies and partnering with renowned medical institutions, Health Sciences Corp aims to revolutionize patient care and improve health outcomes. With its extensive expertise and commitment to scientific advancements, Health Sciences Corp continues to make significant contributions to the ever-evolving healthcare landscape.

What is the business model of Health Sciences?

The business model of Health Sciences Corp focuses on providing innovative healthcare solutions and products. The company combines cutting-edge technology with extensive research and development to deliver superior medical devices, diagnostics, and pharmaceuticals. Health Sciences Corp operates across various segments including medical imaging, healthcare IT, diagnostics, and therapeutics to meet the diverse needs of patients and healthcare providers. By leveraging its expertise and strategic partnerships, Health Sciences Corp aims to improve patient outcomes, enhance healthcare delivery, and contribute to the advancement of the global healthcare industry.

Koji P/E odnos ima Health Sciences 2024?

KGV za Health Sciences trenutno ne može biti izračunato.

Koji je KUV za Health Sciences 2024?

KUV za Health Sciences trenutno ne može biti izračunat.

Koji AlleAktien kvalitetni skor ima Health Sciences?

AlleAktien kvalitativni skor za Health Sciences je 2/10.

Koliki je prihod od Health Sciences 2024?

Prihod trenutno ne može biti izračunat za Health Sciences.

Koliki je profit kompanije Health Sciences 2024?

Profit trenutno ne može biti izračunat za Health Sciences.

Шта ради Health Sciences?

The company Health Sciences Corp is a globally leading provider of diagnostic and therapeutic products. The business model of the company consists of various divisions that focus on the development, manufacturing, and marketing of medical devices, instruments, and procedures. The Medical Devices division specializes in the production of high-tech devices used in medical diagnostics and therapy. These devices include imaging systems such as X-ray, CT, and MRI scanners, as well as other innovative medical instruments. Another important business segment of Health Sciences Corp is the pharmaceutical industry. Here, diverse products are developed and produced for various medical conditions. Targeted medication therapies offer patients the opportunity to effectively manage health problems. In addition to these two strong pillars, there is a third division called Healthcare Services. Here, services related to the medical field are offered, such as consultation, education, and support for medical professionals. Health Sciences Corp develops and manufactures innovative products to meet the needs of patients. Research and development are constantly being advanced to continuously improve medical diagnostic and therapeutic options. The company collaborates closely with other stakeholders in the healthcare sector, such as doctors and hospitals. This close collaboration also enables more effective use of the products in medical practice and improves patient care. Health Sciences Corp is known for its product innovations, such as flow cytometry technology, for which the company was awarded the Nobel Prize. Even today, the company continues to drive research and development of new technologies and procedures. With its wide range of diagnostic and therapeutic products and professionalism in service, Health Sciences Corp offers its customers comprehensive care for health problems. In the age of digitalization, internet-based services have also become an important part of the business model. Health Sciences Corp operates an online platform through which patients can directly access medical experts and consultants. The future for Health Sciences Corp looks promising, as the healthcare sector will continue to grow in importance. The company has a long history of success, allowing it to be among the leading providers of medical diagnostic and therapeutic products in many countries around the world.

Kolika je Health Sciences dividenda?

Health Sciences isplaćuje dividendu od 0 USD raspoređenu preko isplata u toku godine.

Koliko često Health Sciences isplaćuje dividendu?

Dividenda za Health Sciences trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

Šta je Health Sciences ISIN?

ISIN od Health Sciences je US0010582056.

Koji je Health Sciences berzanski simbol?

Oznaka za praćenje akcija kompanije Health Sciences je IWKS.

Kolika je dividenda koju isplaćuje Health Sciences?

U poslednjih 12 meseci, Health Sciences je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Health Sciences će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Health Sciences?

Dividendski prinos od Health Sciences trenutno iznosi .

Kada Health Sciences isplaćuje dividendu?

Health Sciences isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Health Sciences?

Health Sciences je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Health Sciences?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Health Sciences?

Health Sciences se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Health Sciences kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Health Sciences od 8. 7. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 8. 7. 2024..

Kada je Health Sciences poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 8. 7. 2024..

Kolika je bila dividenda od Health Sciences u godini 2023?

U godini 2023 kompanija Health Sciences je isplatila 0 USD kao dividende.

U kojoj valuti Health Sciences isplaćuje dividendu?

Dividende od Health Sciences se isplaćuju u USD.

Ostali pokazatelji i analize od Health Sciences u dubinskoj analizi

Naša analiza akcija za akciju Health Sciences Promet uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Health Sciences Promet. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: